Resideo Technologies: Citizens raises target price to $29 from $22
REZI•Citizens raised its price target for Resideo Technologies to $29 from $22.
Related News
Taysha Gene Therapies Q3 2026 net loss widens 20% to $39.1 million
TSHA•
Beachbody participates in 17th annual Craig-Hallum Alpha Select Conference
BODI•
Aclaris Therapeutics participates in Jefferies Global Healthcare Conference fireside chat
ACRS•
Nebius Group posts Q3 revenue of $980.8 million, expects pre-tax breakeven by end of 2027
NBIS•
Fort Technology announces up to $20 million unsecured convertible debt offering
FRTT•